Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation
Post-operative Atrial Fibrillation (POAF)
About this trial
This is an interventional prevention trial for Post-operative Atrial Fibrillation (POAF)
Eligibility Criteria
Inclusion Criteria: Males and female patients (age 50-79) at the Mitral Valve Clinic/CVC undergoing elective cardiac surgery for mitral valve repair without the Cox MAZE procedure (MVR patients also undergoing CABG and/or tricuspid valve repair are also eligible) In sinus rhythm (no pre-operative atrial fibrillation) Exclusion Criteria: Age ≥ 80 years Diagnosed pre-operative chronic or paroxysmal AF Prior ablation procedure for AF Previous cardiac surgery Implanted pacemaker Active smoker Comorbidities such as congenital or cardiac re-operation Use of antiarrhythmic agents Active inflammatory or infectious disease or malignancy Diagnosed autoimmune disease Corticosteroid or other immunomodulatory or immunosuppressive medication Risk factors for POAF including low ejection fraction (EF) (EF<50%), left atrial (LA) dilation (LA>5.0 cm), and high degree of mitral regurgitation (grade 3-4).
Sites / Locations
- University of Michigan - Michigan Medicine
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Concentrated grape powder
Placebo